A large study of 43 million people found that men under the age of 40 have “A HIGHER RISK of myocarditis” after taking the mRNA vaccines

In February, The Journal of the College of American Pathologists released a terrifying report on cases of two teenage boys who died following mRNA Covid vaccines.  Both boys died in their sleep less than a week after the second dose of the mRNA vaccines was administered, and neither had any known health conditions prior to death. The report further states:

“The key point is that since these boys had died suddenly and unexpectedly in their sleep without resuscitation, if the arrhythmia had been due to the myocardial scar (Boy A) or cardiomegaly (Boy B), then the fulminant, global myocardial injury would not be an expected finding. These two clinical histories support the etiology of the acute myocardial injury as a primary factor not a secondary agonal or post-resuscitative artefact.”

Six months later, a large new study of 43 million people conducted in England found that men under the age of 40 have a higher risk of myocarditis (inflammation of the heart muscle) after taking Pfizer and Moderna mRNA vaccines. The report was published on Monday in the American Heart Association (AMA) journal Circulation.

Although the report is titled “COVID-19 infection poses higher risk for myocarditis than vaccines,” the author could have put a subtitle that says “except for men under 40.” But buried deep down in paragraph 9 of the report, the authors wrote:

“Men under 40 who received a second dose of the Moderna vaccine had a higher risk of myocarditis following vaccination.“

The report goes on to say: “Among men under 40, there were an estimated four extra cases of myocarditis associated with the first dose of the Pfizer vaccine and 14 extra cases with the first dose of the Moderna vaccine for every 1 million men vaccinated. That risk rose with the second dose for all three vaccines studied and was highest for Moderna’s, which had an additional 97 myocarditis cases per 1 million. For unvaccinated men under 40 with COVID-19, there were 16 additional myocarditis cases per million.”

In a news release, Martina Patone, the study’s lead author and a statistician at the University of Oxford Nuffield Department of Primary Health Care Sciences in England, said in a news release: “We found that across this large dataset, the entire COVID-19-vaccinated population of England during an important 12-month period of the pandemic when the COVID-19 vaccines first became available, the risk of myocarditis following COVID-19 vaccination was quite small compared to the risk of myocarditis after COVID-19 infection.”

“These findings are valuable to help inform recommendations on the type of COVID-19 vaccines available for younger people and may also help shape public health policy and strategy for COVID-19 vaccine boosters,” study co-author Julia Hippisley-Cox said in the release. She is a professor of clinical epidemiology and general practice at the University of Oxford.

In June 2021, after reports of hundreds who suffered rare heart inflammation following Pfizer and Moderna COVID-19 mRNA vaccines, The U.S. Food and Drug Administration (FDA) decided to add a warning about the risk of developing heart inflammation to information about the Moderna and Pfizer COVID-19 vaccines. The FDA announcement came after the Centers for Disease Control and Prevention (CDC) said that “evidence grows stronger that Covid vaccine is linked to a heart issue called myocarditis.”

In a June 25, 2021 notice, The FDA said:

“Today, the FDA is announcing revisions to the patient and provider fact sheets for the Moderna and Pfizer-BioNTech COVID-19 vaccines regarding the suggested increased risks of myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the tissue surrounding the heart) following vaccination.”

Below is a video of the detailed analysis of the report from Kim Iversen.